Related Experiment Video
Updated: Nov 14, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left Ventricular Diastolic Dysfunction Is Associated With the Prevalence of Paroxysmal Atrial Fibrillation Determined
Takashi Akima1, Katsutoshi Sekine2, Koki Yamaoka1
1Department of Cardiology, Saitama-Municipal Hospital Saitama Japan.
Insights
Left ventricular diastolic dysfunction (LVDD) severity, graded by echocardiography, is linked to paroxysmal atrial fibrillation (PAF) prevalence. Higher LVDD grades, especially Grade 3, show a significant association with PAF, suggesting potential new therapeutic markers.
Area of Science:
- Cardiology
- Echocardiography
- Cardiac Electrophysiology
Background:
- The link between left ventricular diastolic dysfunction (LVDD) and paroxysmal atrial fibrillation (PAF) is not well-defined due to a lack of standardized LVDD assessment.
- Current American Society of Echocardiography guidelines offer a framework for grading LVDD, enabling more precise investigation.
Purpose of the Study:
- To investigate the association between LVDD severity, categorized by the latest echocardiographic criteria, and the prevalence of PAF.
- To explore if LVDD grading can serve as a predictor for PAF development.
Main Methods:
- A retrospective analysis of 2,063 patients without persistent atrial fibrillation who underwent echocardiography.
- Patients were classified into six LVDD categories: No-LVDD, Borderline, Grade 1, Indeterminate, Grade 2, and Grade 3.
- PAF prevalence was calculated for each LVDD grade, with multivariate analysis adjusting for patient characteristics.
Main Results:
- PAF prevalence was significantly higher in patients with Grade 3 LVDD (54.5%) compared to other grades.
- In patients with reduced left ventricular ejection fraction, PAF prevalence increased proportionally with LVDD grade.
- Multivariate analysis confirmed a significant association between LVDD severity and PAF prevalence.
Conclusions:
- LVDD severity, as determined by current echocardiographic guidelines, is associated with the prevalence of PAF.
- These findings highlight the potential of LVDD assessment as a tool for identifying patients at risk for PAF and developing novel therapeutic strategies.
Abstract:
The relationship between left ventricular diastolic dysfunction (LVDD) and paroxysmal atrial fibrillation (PAF) remains unclear because of a lack of standard measures to evaluate LVDD. Accordingly, we examined the association between the prevalence of PAF and each LVDD grade determined according to the latest American Society of Echocardiography guidelines. In all, 2,063 patients without persistent AF who underwent echocardiography at Saitama Municipal Hospital from July 2016 to June 2017 were included in the study. Patients were divided into LVDD 6 categories: No-LVDD (n=1,107), Borderline (n=392), Grade 1 (n=204), Indeterminate (n=62), Grade 2 (n=254), and Grade 3 (n=44). PAF was documented in 111 (10.0%), 81 (20.7%), 28 (13.7%), 6 (9.7%), 52 (20.5%), and 24 (54.5%) patients in the No-LVDD, Borderline, Grade 1, Indeterminate, Grade 2, and Grade 3 categories, respectively. PAF prevalence was higher in patients with Grade 3 LVDD across the whole study population. Subgroup analyses showed that the prevalence of PAF increased with increased LVDD grade in patients with reduced left ventricular ejection fraction. This relationship was significant in multivariate analysis including various patient characteristics. LVDD severity determined on the basis of the latest echocardiographic criteria was associated with the prevalence of PAF. The present findings shed light on the development of new therapeutic markers for PAF.
Related Concept Videos
Heart Failure II: Pathophysiology
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests

